Jw Therapeutics Co Stock Performance

JWCTF Stock  USD 0.36  0.00  0.00%   
The company owns a Beta (Systematic Risk) of -0.12, which attests to not very significant fluctuations relative to the market. As returns on the market increase, returns on owning JW (Cayman) are expected to decrease at a much lower rate. During the bear market, JW (Cayman) is likely to outperform the market. At this point, JW Therapeutics has a negative expected return of -0.3%. Please make sure to check out JW (Cayman)'s variance, as well as the relationship between the skewness and day typical price , to decide if JW Therapeutics performance from the past will be repeated sooner or later.

Risk-Adjusted Performance

Weakest

 
Weak
 
Strong
Over the last 90 days JW Therapeutics Co has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fragile performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in February 2026. The current disturbance may also be a sign of long-run up-swing for the company stockholders. ...more
Begin Period Cash Flow2.6 B
Total Cashflows From Investing Activities-137.1 M
  

JW (Cayman) Relative Risk vs. Return Landscape

If you would invest  45.00  in JW Therapeutics Co on October 29, 2025 and sell it today you would lose (9.00) from holding JW Therapeutics Co or give up 20.0% of portfolio value over 90 days. JW Therapeutics Co is currently producing negative expected returns and takes up 3.0805% volatility of returns over 90 trading days. Put another way, 27% of traded pink sheets are less volatile than JWCTF, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon JW (Cayman) is expected to under-perform the market. In addition to that, the company is 4.12 times more volatile than its market benchmark. It trades about -0.1 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.09 per unit of volatility.

JW (Cayman) Target Price Odds to finish over Current Price

The tendency of JWCTF Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
Current PriceHorizonTarget PriceOdds to move above the current price in 90 days
 0.36 90 days 0.36 
about 81.24
Based on a normal probability distribution, the odds of JW (Cayman) to move above the current price in 90 days from now is about 81.24 (This JW Therapeutics Co probability density function shows the probability of JWCTF Pink Sheet to fall within a particular range of prices over 90 days) .
Assuming the 90 days horizon JW Therapeutics Co has a beta of -0.12. This indicates as returns on the benchmark increase, returns on holding JW (Cayman) are expected to decrease at a much lower rate. During a bear market, however, JW Therapeutics Co is likely to outperform the market. Additionally JW Therapeutics Co has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial.
   JW (Cayman) Price Density   
       Price  

Predictive Modules for JW (Cayman)

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as JW Therapeutics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of JW (Cayman)'s price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
0.020.333.41
Details
Intrinsic
Valuation
LowRealHigh
0.020.313.39
Details
Naive
Forecast
LowNextHigh
0.010.353.43
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
0.350.360.37
Details

JW (Cayman) Risk Indicators

For the most part, the last 10-20 years have been a very volatile time for the stock market. JW (Cayman) is not an exception. The market had few large corrections towards the JW (Cayman)'s value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold JW Therapeutics Co, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of JW (Cayman) within the framework of very fundamental risk indicators.
α
Alpha over Dow Jones
-0.29
β
Beta against Dow Jones-0.12
σ
Overall volatility
0.05
Ir
Information ratio -0.12

JW (Cayman) Alerts and Suggestions

In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of JW (Cayman) for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for JW Therapeutics can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.
JW Therapeutics generated a negative expected return over the last 90 days
JW Therapeutics has some characteristics of a very speculative penny stock
JW Therapeutics has high historical volatility and very poor performance
JW Therapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 30.8 M. Net Loss for the year was (702.33 M) with profit before overhead, payroll, taxes, and interest of 9.04 M.
JW Therapeutics Co has accumulated about 1.55 B in cash with (561.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 44.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Acquisition by Williams Gregg of 1473214 shares of Vivani Medical at 1.12 subject to Rule 16b-3

JW (Cayman) Fundamentals Growth

JWCTF Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of JW (Cayman), and JW (Cayman) fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on JWCTF Pink Sheet performance.

About JW (Cayman) Performance

By analyzing JW (Cayman)'s fundamental ratios, stakeholders can gain valuable insights into JW (Cayman)'s financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if JW (Cayman) has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if JW (Cayman) has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Ltd, a clinical stage cell therapy company, focuses on developing, manufacturing, and commercializing cell-based immunotherapies for hematological cancers and solid tumors. Ltd was founded in 2016 and is headquartered in Shanghai, the Peoples Republic of China. Jw Cayman is traded on OTC Exchange in the United States.

Things to note about JW Therapeutics performance evaluation

Checking the ongoing alerts about JW (Cayman) for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for JW Therapeutics help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
JW Therapeutics generated a negative expected return over the last 90 days
JW Therapeutics has some characteristics of a very speculative penny stock
JW Therapeutics has high historical volatility and very poor performance
JW Therapeutics has high likelihood to experience some financial distress in the next 2 years
The company reported the revenue of 30.8 M. Net Loss for the year was (702.33 M) with profit before overhead, payroll, taxes, and interest of 9.04 M.
JW Therapeutics Co has accumulated about 1.55 B in cash with (561.2 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.78, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 44.0% of the company shares are held by company insiders
Latest headline from MacroaxisInsider: Acquisition by Williams Gregg of 1473214 shares of Vivani Medical at 1.12 subject to Rule 16b-3
Evaluating JW (Cayman)'s performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate JW (Cayman)'s pink sheet performance include:
  • Analyzing JW (Cayman)'s financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether JW (Cayman)'s stock is overvalued or undervalued compared to its peers.
  • Examining JW (Cayman)'s industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating JW (Cayman)'s management team can have a significant impact on its success or failure. Reviewing the track record and experience of JW (Cayman)'s management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of JW (Cayman)'s pink sheet. These opinions can provide insight into JW (Cayman)'s potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating JW (Cayman)'s pink sheet performance is not an exact science, and many factors can impact JW (Cayman)'s pink sheet market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for JWCTF Pink Sheet analysis

When running JW (Cayman)'s price analysis, check to measure JW (Cayman)'s market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JW (Cayman) is operating at the current time. Most of JW (Cayman)'s value examination focuses on studying past and present price action to predict the probability of JW (Cayman)'s future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JW (Cayman)'s price. Additionally, you may evaluate how the addition of JW (Cayman) to your portfolios can decrease your overall portfolio volatility.
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories